Determining locations of ganglia and plexi in the heart using complex fractionated atrial electrogram

• US 8,359,092 B2
• Filed: 11/21/2008
• Issued: 01/22/2013
• Est. Priority Date: 11/29/2007
• Status: Active Grant

• Current Assignee: Biosense Webster Incorporated (Johnson & Johnson)
• Original Assignee: Biosense Webster Incorporated (Johnson & Johnson)
• Inventors: Hayam, Gal, Jackman, Warren, Nakagawa, Hiroshi
• Primary Examiner(s): Patel, Niketa
• Assistant Examiner(s): VOORHEES, CATHERINE M
• Application Number:
  US12/275,380
• Publication Number:
  US 20090192393A1
• Time in Patent Office: 1,523 Days
• Field of Search: 600508-510, 600515-518, 600522-523
• US Class Current: 600/523
• CPC Class Codes: A61B 2018/00839 Bioelectrical parameters, e.g. ECG, EEG
• CPC Class Codes: A61B 5/283 Invasive
• CPC Class Codes: A61B 5/341 Vectorcardiography [VCG]
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/721 using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured

Abstract

Software and apparatus are provided to automatically detect and map ganglionated plexi that are found within areas of complex fractionated electrograms in cardiac chambers. Electrogram signal are analyzed to count the number of complexes whose amplitude and peak-to-peak intervals meet certain criteria. Functional maps indicating a spatial distribution of the ganglionated plexi and the relative numbers of complex fractionated electrograms are produced for display.

Claims

1. A method for mapping abnormal electrical activity in a heart of a living subject, comprising the steps of:

obtaining electrical signal data from respective locations of the heart in an area of interest;

automatically analyzing the signal data to identify complex fractionated electrograms or complex fractionated electrogram segments therein;

determining if the number of identified complex fractionated electrograms in the area of interest exceed a predetermined threshold for complex fractionated electrograms or if the number of complex fractionated electrogram segments in the area of interest achieve a maximal number;

identifying one or more of the locations in the area of interest as having ganglionated plexi if the number of identified complex fractionated electrograms in the area of interest exceeded the predetermined threshold for complex fractionated electrograms or if the number of complex fractionated electrogram segments in the area of interest achieved the maximal number;

deriving an electroanatomic map of the heart from the signal data that includes a spatial distribution of the complex fractionated electrograms and the ganglionated plexi, the electroanatomical map including a key encoding the number of complex fractionated electrograms in any area of interest; and

displaying the spatial distribution of the complex fractionated electrograms and the ganglionated plexi with the key encoding the number of complex fractionated electrograms in any area of interest of the electroanatomic map.

2. The method according to claim 1, wherein identifying one or more of the locations comprises determining that a number of the complex fractionated electrograms at the one or more of the locations complies with a predefined criterion.

3. The method according to claim 2, wherein compliance with the predefined criterion comprises identifying ones of the locations wherein the complex fractionated electrograms exceed a threshold number.

4. The method according to claim 2, wherein compliance with the predefined criterion comprises identifying ones of the locations having locally maximal numbers of complex fractionated electrograms.

5. The method according to claim 1, further comprising the steps of:

electrically stimulating a selected one of the locations that presumptively contain ganglionated plexi;

recording responsively to the step of electrically stimulating a cardiovascular response comprising at least one of a reduction in sinus rate, a reduction in blood pressure, and a period of asystole; and

thereafter reporting a confirmation of a presence of the ganglionated plexi in the selected one of the locations.

6. The method according to claim 1, wherein deriving an electroanatomic map comprises coding the electroanatomic map according to numbers of the complex fractionated electrograms detected in the respective locations.

7. An apparatus for mapping electrical activity in a heart of a living subject, comprising:

a memory for storing electrical signal data from respective locations in an area of interest of the heart;

a processor configured to access the memory and automatically analyze the signal data to identify complex fractionated electrograms or complex fractionated electrogram segments in the area of interest, and to determine when the number of identified complex fractionated electrograms in the area of interest exceed a predetermined threshold for complex fractionated electrograms or when the number of complex fractionated electrogram segments in the area of interest achieve a maximal number, and identify one or more of the area of interests as having ganglionated plexi when the number of identified complex fractionated electrograms in the area of interest exceeded the predetermined threshold for complex fractionated electrograms or when the number of complex fractionated electrogram segments in the area of interest achieved the maximal number;

an electroanatomic map of the heart is derived from the signal data that includes a spatial distribution of the complex fractionated electrograms and the ganglionated plexi, the electroanatomical map including a key encoding the number of complex fractionated electrograms in any area of interest; and

a display for presenting the electroanatomic map to an operator.

8. The apparatus according to claim 7, wherein the processor is operative to identify one or more of the locations by determining that a number of the complex fractionated electrograms at the one or more of the locations complies with a predefined criterion.

9. The apparatus according to claim 8, wherein compliance with the predefined criterion comprises an identification of ones of the locations wherein the complex fractionated electrograms exceed a threshold number.

10. The apparatus according to claim 8, wherein compliance with the predefined criterion comprises an identification of ones of the locations having locally maximal numbers of complex fractionated electrograms.

11. The apparatus according to claim 7, wherein the processor is operative to record responsively to an electrical stimulation of selected ones of the locations a cardiovascular response comprising at least one of a reduction in sinus rate, a reduction in blood pressure, and a period of asystole;

and thereafter report a confirmation of a presence of the ganglionated plexi in the selected ones of the locations.

12. The apparatus according to claim 7, wherein the processor is operative to code the electroanatomic map according to numbers of the complex fractionated electrograms detected in the respective locations.